Bain helps push Affinivax to next stage with $120M round, as PhII data loom on a lead effort to do something new in vaccines

Affinivax CEO Steven Brugger has always looked for unconventional ways to go about the business of vaccine R&D. The Gates Foundation put up a lot …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bain helps push Affini­vax to next stage with $120M round, as PhII da­ta loom on a lead ef­fort to do some­thing new in vac­cines